BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Treiber G, Malfertheiner P, Klotz U. Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic. Expert Opin Pharmacother 2007;8:329-50. [PMID: 17266468 DOI: 10.1517/14656566.8.3.329] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Zapała L, Kosińska M, Woźnicka E, Byczyński Ł, Zapała W. Synthesis, spectral and thermal study of La(III), Nd(III), Sm(III), Eu(III), Gd(III) and Tb(III) complexes with mefenamic acid. J Therm Anal Calorim 2016;124:363-74. [DOI: 10.1007/s10973-015-5120-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 3.1] [Reference Citation Analysis]
2 Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935-951. [PMID: 18679668 DOI: 10.1007/s00228-008-0538-y] [Cited by in Crossref: 204] [Cited by in F6Publishing: 188] [Article Influence: 14.6] [Reference Citation Analysis]
3 Andrews PC, Blair VL, Ferrero RL, Junk PC, Kedzierski L, Peiris RM. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents. Dalton Trans 2014;43:1279-91. [PMID: 24190067 DOI: 10.1039/c3dt52544a] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
4 Andrews PC, Ferrero RL, Junk PC, Peiris RM. A sweeter way to combat Helicobacter pylori? Bismuth(III) complexes and oxido-clusters derived from non-nutritive sweeteners and their activity against H. pylori. Journal of Organometallic Chemistry 2013;724:88-94. [DOI: 10.1016/j.jorganchem.2012.10.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Guo Y, Guan C, Wan H, Zhang Z, Li H, Sun H, Xia W. Inactivation of NikR from Helicobacter pylori by a bismuth drug. J Inorg Biochem 2019;196:110685. [PMID: 30999221 DOI: 10.1016/j.jinorgbio.2019.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lu B, Wang J, Li J, Liu L, Chen Y. Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial. Helicobacter 2019;24:e12566. [DOI: 10.1111/hel.12566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 El-shenawy A, Diab M, Shemis M, El-ghannam M, Salem D, Abdelnasser M, Shahin M, Abdel-hady M, El-sherbini E, Saber M. Detection of Helicobacter pylori vacA , cagA and iceA1 virulence genes associated with gastric diseases in Egyptian patients. Egyptian Journal of Medical Human Genetics 2017;18:365-71. [DOI: 10.1016/j.ejmhg.2017.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
8 Dash RP, Rais R, Srinivas NR. Stereoselective and nonstereoselective pharmacokinetics of rabeprazole – an overview. Xenobiotica 2018;48:422-32. [DOI: 10.1080/00498254.2017.1307470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Anamika A, Singh R, Manar KK, Yadav CL, Kumar A, Singh RK, Drew MGB, Singh N. Impact of substituents on the crystal structures and anti-leishmanial activity of new homoleptic Bi( iii ) dithiocarbamates. New J Chem 2019;43:16921-31. [DOI: 10.1039/c9nj04477a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
10 Graham DY. Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol. 2009;7:145-148. [PMID: 19026766 DOI: 10.1016/j.cgh.2008.10.024] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
11 Andrews PC, Ferrero RL, Forsyth CM, Junk PC, Maclellan JG, Peiris RM. Bismuth(III) Saccharinate and Thiosaccharinate Complexes and the Effect of Ligand Substitution on Their Activity against Helicobacter pylori. Organometallics 2011;30:6283-91. [DOI: 10.1021/om2008869] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
12 Martini S, Bonechi C, Rossi C, Figura N. Increased susceptibility to resveratrol of Helicobacter pylori strains isolated from patients with gastric carcinoma. J Nat Prod. 2011;74:2257-2260. [PMID: 21936484 DOI: 10.1021/np100761u] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Andrews PC, Blair VL, Ferrero RL, Junk PC, Kumar I. Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate. Chem Commun (Camb) 2013;49:2870-2. [PMID: 23450139 DOI: 10.1039/c3cc40645h] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
14 Andleeb S, Imtiaz-Ud-Din, Rauf MK, Azam SS, Haq IU, Tahir MN, Zaman N. Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies. J Biol Inorg Chem 2022. [PMID: 34981207 DOI: 10.1007/s00775-021-01919-y] [Reference Citation Analysis]
15 Andrews PC, Ferrero RL, Junk PC, Kumar I, Luu Q, Nguyen K, Taylor JW. Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori. Dalton Trans 2010;39:2861-8. [PMID: 20200713 DOI: 10.1039/c000164c] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
16 Selgrad M, Kandulski A, Malfertheiner P. Helicobacter pylori: diagnosis and treatment. Curr Opin Gastroenterol. 2009;25:549-556. [PMID: 19696666 DOI: 10.1097/mog.0b013e32833159f2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
17 Figura N, Marcolongo R, Cavallo G, Santucci A, Collodel G, Spreafico A, Moretti E. Polysorbate 80 and Helicobacter pylori: a microbiological and ultrastructural study. BMC Microbiol 2012;12:217. [PMID: 22998649 DOI: 10.1186/1471-2180-12-217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]